Posted On: 12/02/2015 11:34:27 AM
Post# of 23100
XOMA: Now is at a good entry point at $1.42. The following news was release yesterday and pushed the stock to $1.65, but since then it cooled off a little and now is time to get in:
Novo Nordisk A/S has agreed to buy the global rights to Xoma Corp.'s Type 2 diabetes treatment in a deal worth up to $295 million.
The price tag includes a $5 million upfront payment to Xoma and up to $290 million in milestones. Xoma also is eligible for royalties on product sales.
Novo Nordisk A/S has agreed to buy the global rights to Xoma Corp.'s Type 2 diabetes treatment in a deal worth up to $295 million.
The price tag includes a $5 million upfront payment to Xoma and up to $290 million in milestones. Xoma also is eligible for royalties on product sales.
(0)
(0)
